Performance Assessment of Dynamic Spiral Scan Modes With Variable Pitch for Quantitative Perfusion Computed Tomography:

JOG Technique Versus Nonspiral Axial Scan in Pancreatic Perfusion Computed Tomography Imaging and Their Preliminary Application

OBJECTIVE

The aim of this study was to investigate the advantages and disadvantages of JOG technique in pancreatic perfusion computed tomography (CT) imaging.

METHODS

First, 40 male patients with nonpancreatic diseases, aged 40 to 60 years, were averagely assigned into 2 groups (A and B). Patients in group A and B underwent nonspiral axial perfusion and JOG technique CT scans of the pancreas, respectively. Second, 23 patients with pancreatic masses were randomly assigned into nonspiral axial scan and JOG groups.

RESULTS

There were no significant differences in all perfusion parameters among the pancreatic head, body, and tail within groups (P > 0.05). Perfusion and time to peak of the pancreatic head, body, and tail differed significantly between groups A and B (P < 0.05). There were significant differences in perfusion parameter values between pancreatic carcinoma tissue and normal pericarcinoma tissue in the nonspiral axial scan group. In the JOG group, perfusion and time to peak differed significantly (P < 0.05).

CONCLUSIONS

The JOG technique should be cautiously selected on pancreatic perfusion CT scans.

Cardiovascular Imaging: The Past and the Future, Perspectives in Computed Tomography and Magnetic Resonance Imaging

Today's noninvasive imaging of the cardiovascular system has revolutionized the approach to various diseases and has substantially affected prognostic information. Cardiovascular magnetic resonance (MR) and computed tomographic (CT) imaging are at center stage of these approaches, although 5 decades ago, these technologies were unheard of. Both modalities had their inception in the 1970s with a primary focus on noncardiovascular applications. The technical development of the various decades, however, substantially pushed the envelope for cardiovascular MR and CT applications. Within the past 10-15 years, MR and CT technologies have pushed each other in cardiac applications; and without the "rival" modality, neither one would likely not have reached its potential today. This view on the history of MR and CT in the field of cardiovascular applications provides insight into the story of success of applications that once have been ideas only but are at prime time today.

Technical prerequisites and imaging protocols for CT perfusion imaging in oncology

The aim of this review article is to define the technical prerequisites of modern state-of-the-art CT perfusion imaging in oncology at reasonable dose levels. The focus is mainly on abdominal and thoracic tumor imaging, as they pose the largest challenges with respect to attenuation and patient motion. We will show that low kV dynamic scanning in conjunction with detection technology optimized for low photon fluxes has the highest impact on reducing dose independently of other choices made in the protocol selection. We discuss, derived from relatively simple first principles, on what appropriate temporal sampling and total scan duration depend on and why optimized contrast medium injection protocols are also essential in limiting dose. Finally we will examine the possibility of simultaneously extracting standard morphological and functional information from one single 4D examination as a potential enabler for a more widespread use of dynamic contrast enhanced CT in oncology.

Attenuation-based automatic kilovolt (kV)-selection in computed tomography of the chest: effects on radiation exposure and image quality

OBJECTIVES

To evaluate an automated attenuation-based kV-selection in computed tomography of the chest in respect to radiation dose and image quality, compared to a standard 120 kV protocol.

MATERIALS AND METHODS

104 patients were examined using a 128-slice scanner. Fifty examinations (58 ± 15 years, study group) were performed using the automated adaption of tube potential (100-140 kV), based on the attenuation profile of the scout scan, 54 examinations (62 ± 14 years, control group) with fixed 120 kV. Estimated CT dose index (CTDI) of the software-proposed setting was compared with a 120 kV protocol. After the scan CTDI volume (CTDIvol) and dose length product (DLP) were recorded. Image quality was assessed by region of interest (ROI) measurements, subjective image quality by two observers with a 4-point scale (3--excellent, 0--not diagnostic).

RESULTS

The algorithm selected 100 kV in 78% and 120 kV in 22%. Overall CTDIvol reduction was 26.6% (34% in 100 kV) overall DLP reduction was 22.8% (32.1% in 100 kV) (all p<0.001). Subjective image quality was excellent in both groups.

CONCLUSION

The attenuation based kV-selection algorithm enables relevant dose reduction (~27%) in chest-CT while keeping image quality parameters at high levels.

First-pass CT perfusion in small peripheral lung cancers: effect of the temporal interval between scan acquisitions on the radiation dose and quantitative vascular parameters

RATIONALE AND OBJECTIVES

To evaluate the effect of the temporal interval (TI) between scan acquisitions on the radiation dose and vascular parameters of computed tomography perfusion (CTP) in small peripheral lung cancers.

MATERIALS AND METHODS

With 7 excluded, 40 patients with peripheral lung cancer (diameter ≤4 cm) prospectively underwent a 30-second CTP study. Vascular parameters were calculated for TI datasets of 0, 1, 1.5, 2, 2.5, and 3.5 seconds. With the TI and tumor diameter as fixed effects, univariate general linear model analysis was used to compare the vascular parameters at interval datasets with the reference CTP of 0 seconds.

RESULTS

The TI had an impact on the blood flow and transit time (P < .001 for both) but not on the blood volume and permeability surface area. The diameter influenced four vascular parameters (P < .001 for all). Compared to the reference, no statistical differences were found in the four parameters at intervals of 0.5, 1, and 1.5 seconds (P > .05 for all). In addition, blood flow was overestimated and transit was underestimated with increasing intervals of 2, 2.5, and 3.5 seconds (P < .05 for all), but not the remaining parameters. An increased TI of 0.5-1.5 seconds resulted in an estimated radiation dose reduction of 50-73%.

CONCLUSION

The TI of 1.5 seconds between scan acquisitions in first-pass phase of CTP could be used to optimally balance the radiation dose and quantitative estimation in small peripheral lung cancers.

Carotid CTA: radiation exposure and image quality with the use of attenuation-based, automated kilovolt selection

BACKGROUND AND PURPOSE

CTA is considered the imaging modality of choice in evaluating the supraaortic vessels in many institutions, but radiation exposure remains a matter of concern. The objective of the study was to evaluate a fully automated, attenuation-based kilovolt selection algorithm in carotid CTA in respect to radiation dose and image quality compared with a standard 120-kV protocol.

MATERIALS AND METHODS

Ninety-eight patients were included: 53 examinations (patient age, 66 ± 12 years) were performed by use of automated adaption of tube potential (80-140 kV) on the basis of the attenuation profile of the scout scan (study group), and 45 examinations (patient age, 67 ± 11 years) were performed by use of a standard 120-kV protocol (control group). CT dose index volume and dose-length product were recorded from the examination protocol. Image quality was assessed by ROI measurements and calculations of SNR and contrast-to-noise ratio. Subjective image quality was evaluated by 2 observers with the use of a 4-point scale (3, excellent; 0, not diagnostic).

RESULTS

Subjective image quality was rated as "excellent" or "good" in all examinations (study group, 2.8; control group, 2.8). The algorithm automatically selected 100 kV in 47% and 80 kV in 34%; 120 kV was retained in 19%. An elevation to 140 kV did not occur. Compared with the control group, overall CT dose index volume reduction was 33.7%; overall dose-length product reduction was 31.5%. In the low-kilovolt scans, image noise and mean attenuation of ROIs inside the carotid arteries were significantly higher than in 120-kV scans, resulting in a constant or increased (80-kV group) contrast-to-noise ratio.

CONCLUSIONS

The attenuation-based, kilovolt selection algorithm enables a dose reduction of >30% in carotid artery CTA while maintaining contrast-to-noise ratio and subjective image quality at adequate levels.

A phantom approach to interscanner comparability of computed tomographic brain perfusion parameters

OBJECTIVE

This study aimed to create a phantom, which allows reproducible computed tomography perfusion experiments, and to identify the influence of contrast bolus configuration, scan parameters, and scanner hardware on the calculation of perfusion parameters.

METHODS

A discoid perfusion phantom with centrifugally directed flow was constructed. Brain parenchyma was simulated by inert polyoxymethylene spheres. Repeated measurements were performed with variations of the above-mentioned factors, and their effects on perfusion results were analyzed.

RESULTS

Calculated flow values measured during experiments were reproducible and showed good correlation with the true flow (R = 0.995, P < 0.01). Tube voltage, injection rate of the contrast agent, the mathematical perfusion algorithm, and the hardware of the scanner hardware had a reproducible influence on calculated perfusion results.

CONCLUSIONS

In the long term, perfusion phantoms might be helpful in identifying hardware-specific and protocol-related factors of different computed tomography scanners to improve comparability of different scanners and scanning protocols.

Performance evaluation of a C-Arm CT perfusion phantom

PURPOSE

Brain perfusion measurement in stroke patients provides important information on the infarct area and state of involved tissue. Interventional C-Arm angiography systems can provide perfusion measurements. A CT perfusion phantom was developed for C-Arm perfusion imaging to test and evaluate this method and to aid in the design and validation of scan protocols.

METHODS

A phantom test device was designed based on the anatomy of the human head. Four feeding arteries divided into sixteen sub-branches that lead into a sintered board simulating brain parenchyma. Perfusion measurements were performed using two conventional clinical CT scanners as the gold standard and with a C-Arm CT system to test and compare the implementations. The phantom's input parameters, contrast medium and flow properties were varied. A cerebral perfusion deficit was simulated by occlusion of a feeding artery tube.

RESULTS

CT perfusion maps of the sintered board brain tissue surrogate were computed and qualitatively compared for both conventional CT and C-Arm CT systems. A characteristic flow pattern of the tissue board was identifiable in both modalities. The characteristic flow pattern of the resulting perfusion maps is reproducible. The calculated flow and volume were directly related.

CONCLUSIONS

A new CT perfusion phantom was developed and tested. This phantom is an appropriate model for CT-based tissue perfusion measurements in both conventional CT scanners and C-Arm CT scanners. The influence of input parameter changes can be visualized. Perfusion deficits after occlusion of a feeding artery are readily simulated and identified with CT.

Liver perfusion imaging in patients with primary and metastatic liver malignancy: prospective comparison between 99mTc-MAA spect and dynamic CT perfusion

RATIONALE AND OBJECTIVES

To prospectively analyze the correlation between parameters of liver perfusion from technetium99m-macroaggregates of albumin (99mTc-MAA) single photon emission computed tomography (SPECT) with those obtained from dynamic CT perfusion in patients with primary or metastatic liver malignancy.

MATERIALS AND METHODS

Twenty-five consecutive patients (11 women, 14 men; mean age 60.9 ± 10.8; range: 32-78 years) with primary (n = 5) or metastatic (n = 20) liver malignancy planned to undergo selective internal radiotherapy underwent dynamic contrast-enhanced CT liver perfusion imaging (four-dimensional spiral mode, scan range 14.8 cm, 15 scans, cycle time 3 seconds) and 99m)Tc-MAA SPECT after intraarterial injection of 180 MBq 99mTc-MAA on the same day. Data were evaluated by two blinded and independent readers for the parameters arterial liver perfusion (ALP), portal venous perfusion (PVP), and total liver perfusion (TLP) from CT, and the 99mTc-MAA uptake-ratio of tumors in relation to normal liver parenchyma from SPECT.

RESULTS

Interreader agreements for quantitative perfusion parameters were high for dynamic CT (r = 0.90-0.98, each P < .01) and 99mTc -MAA SPECT (r = 0.91, P < .01). Significant correlation was found between 99mTc-MAA uptake ratio and ALP (r = 0.7, P < .01) in liver tumors. No significant correlation was found between 99mTc-MAA uptake ratio, PVP (r = -0.381, P = .081), and TLP (r = 0.039, P = .862).

CONCLUSION

This study indicates that in patients with primary and metastatic liver malignancy, ALP obtained by dynamic CT liver perfusion significantly correlates with the 99mTc-MAA uptake ratio obtained by SPECT.

Multifunctional profiling of non-small cell lung cancer using 18F-FDG PET/CT and volume perfusion CT

The aim of this study was to investigate correlations between glucose metabolism registered by (18)F-FDG PET/CT and tumor perfusion quantified by volume perfusion CT and immunohistochemical markers Ki67 and microvessel density (MVD) in patients with non-small cell lung cancer (NSCLC).

METHODS

Between February 2010 and April 2011, 24 consecutive patients (21 women, 3 men; mean age ± SD, 67.6 ± 6.8 y; age range, 55.6-81.3 y) with histologically proven NSCLC (14 adenocarcinoma, 9 squamous cell lung carcinoma [SCC], and 1 mixed adenocarcinoma and SCC) underwent (18)F-FDG PET/CT and additional volume perfusion CT. Maximum standardized uptake value (SUV(max)), mean SUV, and the metabolic tumor volume were used for (18)F-FDG uptake quantification. Blood flow (BF), blood volume (BV), flow extraction product (K(trans)), and standardized perfusion value (SPV) were determined as CT perfusion parameters. Both perfusion parameters and (18)F-FDG uptake values were subsequently related to the histologic subtypes, proliferation marker Ki67, MVD according to CD34 staining, and total tumor volume.

RESULTS

Mean SUV, SUV(max), and the metabolic tumor volume (mL) were 5.8, 8.7, and 32.3, respectively, in adenocarcinoma and 8.5, 12.9, and 16.8, respectively, in SCC. Mean BF (mL/100 mL/min), mean BV (mL/100 mL), and K(trans) (mL/100 mL/min) were 35.4, 7.3, and 27.8, respectively, in adenocarcinoma and 35.5, 10.0, and 27.8, respectively, in SCC. Moderate correlations were found between the (18)F-FDG PET/CT parameters and Ki67 as well as between CT perfusion parameters and MVD but not vice versa. For all tumors, the following correlations were found: between SUV(max) and Ki67, r = 0.762 (P = 0.017); between SUV(max) and MVD, r = -0.237 (P = 0.359); between mean BF and Ki67, r = -0.127 (P = 0.626); and between mean BF and MVD, r = 0.467 (P = 0.059). Interestingly, correlations between the BF-metabolic relationship and total tumor volume were higher in SCC (r = 0.762, P = 0.017) than in adenocarcinoma (r = -0.0791, P = 0.788).

CONCLUSION

(18)F-FDG uptake correlates with Ki67, whereas BF, BV, and K(trans) correlate with MVD. Therefore, (18)F-FDG uptake and perfusion parameters provide complementary functional information. An improved tumor profiling will be beneficial for both prognosis and therapy response evaluation in these tumors.

Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography

Dynamic contrast-enhanced computed tomography (DCE-CT) assesses the vascular support of tumours through analysis of temporal changes in attenuation in blood vessels and tissues during a rapid series of images acquired with intravenous administration of iodinated contrast material. Commercial software for DCE-CT analysis allows pixel-by-pixel calculation of a range of validated physiological parameters and depiction as parametric maps. Clinical studies support the use of DCE-CT parameters as surrogates for physiological and molecular processes underlying tumour angiogenesis. DCE-CT has been used to provide biomarkers of drug action in early phase trials for the treatment of a range of cancers. DCE-CT can be appended to current imaging assessments of tumour response with the benefits of wide availability and low cost. This paper sets out guidelines for the use of DCE-CT in assessing tumour vascular support that were developed using a Delphi process. Recommendations encompass CT system requirements and quality assurance, radiation dosimetry, patient preparation, administration of contrast material, CT acquisition parameters, terminology and units, data processing and reporting. DCE-CT has reached technical maturity for use in therapeutic trials in oncology. The development of these consensus guidelines may promote broader application of DCE-CT for the evaluation of tumour vascularity. Key Points • DCE-CT can robustly assess tumour vascular support • DCE-CT has reached technical maturity for use in therapeutic trials in oncology • This paper presents consensus guidelines for using DCE-CT in assessing tumour vascularity.

Multi-organ perfusion CT in the abdomen using a 320-detector row CT scanner: preliminary results of perfusion changes in the liver, spleen, and pancreas of cirrhotic patients

PURPOSE

To utilize 320-detector row CT in perfusion CT of multiple abdominal organs and to compare the tissue perfusion between patients with and without liver cirrhosis.

MATERIALS AND METHODS

This study included 21 patients with cirrhosis and 20 without cirrhosis. The 320-detector row CT scanner enabled multi-organ perfusion CT without requiring the scanner table to be moved. Perfusion was calculated using the maximum slope model for the aorta, the portal vein, the right and left lobes of the liver, the head and body of the pancreas, the spleen, and the corpus and antrum of the stomach. Perfusion in each organ of patients with and without cirrhosis was compared.

RESULTS

Portal venous perfusion of the right and left lobes of the liver in patients with cirrhosis (117 and 100 mL min(-1)100mL(-1), respectively) was significantly less than that in patients without cirrhosis (213 and 174 mL min(-1)100mL(-1), respectively; p=0.0081 and 0.0294, respectively). Arterial perfusion of the spleen (111 mL min(-1)100mL(-1)) and the body of the pancreas (112 mL min(-1)100mL(-1)) in patients with cirrhosis was also significantly decreased compared with that in patients without cirrhosis (spleen, 162 mL min(-1)100mL(-1), p=0.0020; body of pancreas, 133 mL min(-1)100mL(-1), p=0.0405).

CONCLUSION

The results of the perfusion CT suggest that arterial perfusion of the spleen and the body of the pancreas, as well as portal perfusion of the liver, in cirrhotic patients was decreased compared with that in non-cirrhotic patients.

Porcine ex vivo liver phantom for dynamic contrast-enhanced computed tomography: development and initial results

OBJECTIVES

: To demonstrate the feasibility of developing a fixed, dual-input, biologic liver phantom for dynamic contrast-enhanced computed tomography (CT) imaging and to report initial results of use of the phantom for quantitative CT perfusion imaging.

MATERIALS AND METHODS

: Porcine livers were obtained from completed surgical studies and perfused with saline and fixative. The phantom was placed in a body-shaped, CT-compatible acrylic container and connected to a perfusion circuit fitted with a contrast injection port. Flow-controlled contrast-enhanced imaging experiments were performed using 128-slice and 64-slice dual-source multidetector CT scanners. CT angiography protocols were used to obtain portal venous and hepatic arterial vascular enhancement, reproduced over a period of 4 to 6 months. CT perfusion protocols were used at different input flow rates to correlate input flow with calculated tissue perfusion, to test reproducibility, and to determine the feasibility of simultaneous dual-input liver perfusion. Histologic analysis of the liver phantom was also performed.

RESULTS

: CT angiogram 3-dimensional reconstructions demonstrated homogenous tertiary and quaternary branching of the portal venous system to the periphery of all lobes of the liver as well as enhancement of the hepatic arterial system to all lobes of the liver and gallbladder throughout the study period. For perfusion CT, the correlation between the calculated mean tissue perfusion in a volume of interest and input pump flow rate was excellent (R = 0.996) and color blood flow maps demonstrated variations in regional perfusion in a narrow range. Repeat perfusion CT experiments demonstrated reproducible time-attenuation curves, and dual-input perfusion CT experiments demonstrated that simultaneous dual input liver perfusion is feasible. Histologic analysis demonstrated that the hepatic microvasculature and architecture appeared intact and well preserved at the completion of 4 to 6 months of laboratory experiments and contrast-enhanced imaging.

CONCLUSIONS

: We have demonstrated successful development of a porcine liver phantom using a flow-controlled extracorporeal perfusion circuit. This phantom exhibited reproducible dynamic contrast-enhanced CT of the hepatic arterial and portal venous system over a 4- to 6-month period.

Intraobserver and interobserver agreement of volume perfusion CT (VPCT) measurements in patients with lung lesions

OBJECTIVES

To evaluate intraobserver and interobserver agreement of manually encompassed lung lesions for perfusion measurements using volume-perfusion computed tomography (VPCT).

MATERIALS AND METHODS

Institutional review board approval and informed consent were obtained. HIPAA guidelines were followed. A 65-s dynamic study was acquired with scan parameters 80 kV, 60 mAs (80 mAs for patients ≥ 70 kg), 128 × 0.6mm collimation. Blood flow (BF), blood volume (BV) and K(trans) parameters were determined by syngo volume perfusion CT body with 88 lesions analyzed retrospectively.

RESULTS

Within-subject coefficients of variation for intraobserver agreement (range 6.59-12.82%) were superior to those for interobserver agreement (range 21.75-38.30%). Size-dependent analysis revealed lower agreements for lesions <4 cm as compared to larger lesions. Additionally, agreements of the upper, middle and lower lung zones were different.

CONCLUSIONS

Intraobserver agreement was substantial for VPCT lung cancer perfusion measurements encouraging the use for tumor characterization and therapy response monitoring. Interobserver agreement is limited and unexperienced readers should be trained before using this new method.